tiprankstipranks
Trending News
More News >
Neuphoria Therapeutics (NEUP)
NASDAQ:NEUP
US Market
Advertisement

Neuphoria Therapeutics (NEUP) Ratios

Compare
283 Followers

Neuphoria Therapeutics Ratios

NEUP's free cash flow for Q3 2025 was $0.99. For the 2025 fiscal year, NEUP's free cash flow was decreased by $ and operating cash flow was $0.75. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 22Dec 21
Liquidity Ratios
Current Ratio
11.01 3.45 4.87 12.46 13.10
Quick Ratio
11.01 3.45 4.87 12.46 13.10
Cash Ratio
10.98 3.29 4.42 10.00 12.07
Solvency Ratio
1.38 -1.46 -3.16 -2.46 -1.05
Operating Cash Flow Ratio
0.27 -3.83 -5.34 -6.48 -3.19
Short-Term Operating Cash Flow Coverage
13.29 -443.27 0.00 0.00 0.00
Net Current Asset Value
$ 12.37M$ 3.04M$ 6.77M$ 22.99M$ 18.23M
Leverage Ratios
Debt-to-Assets Ratio
<0.01 <0.01 0.01 0.01 0.02
Debt-to-Equity Ratio
<0.01 0.02 0.02 0.01 0.02
Debt-to-Capital Ratio
<0.01 0.02 0.02 0.01 0.02
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.18 1.58 1.30 1.15 1.14
Debt Service Coverage Ratio
72.22 -514.70 -1.47K -767.48 -4.96
Interest Coverage Ratio
0.00 0.00 -1.53K -794.21 -10.15
Debt to Market Cap
<0.01 <0.01 0.00 0.00 0.00
Interest Debt Per Share
<0.01 <0.01 <0.01 <0.01 0.02
Net Debt to EBITDA
-8.30 0.72 0.56 1.58 4.60
Profitability Margins
Gross Profit Margin
96.83%0.00%0.00%100.00%0.00%
EBIT Margin
8.74%0.00%0.00%-8316.20%0.00%
EBITDA Margin
12.97%0.00%0.00%-7895.38%0.00%
Operating Profit Margin
-4.93%0.00%0.00%-8095.15%0.00%
Pretax Profit Margin
35.70%0.00%0.00%-8326.39%0.00%
Net Profit Margin
37.20%0.00%0.00%-8253.64%0.00%
Continuous Operations Profit Margin
37.20%0.00%0.00%-8253.64%0.00%
Net Income Per EBT
104.21%99.44%99.35%99.13%97.89%
EBT Per EBIT
-724.09%87.07%99.82%102.86%74.52%
Return on Assets (ROA)
18.97%-56.03%-74.86%-33.32%-16.03%
Return on Equity (ROE)
31.37%-88.58%-97.14%-38.23%-18.27%
Return on Capital Employed (ROCE)
-2.65%-75.11%-83.49%-34.45%-22.97%
Return on Invested Capital (ROIC)
-2.75%-74.21%-82.58%-34.06%-22.41%
Return on Tangible Assets
33.70%-114.83%-155.63%-51.07%-27.25%
Earnings Yield
0.12%-1.25%-0.44%-0.16%-0.04%
Efficiency Ratios
Receivables Turnover
636.90 0.00 0.00 0.04 0.00
Payables Turnover
0.67 0.00 0.00 0.00 0.00
Inventory Turnover
0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
123.49 0.00 0.00 0.39 0.00
Asset Turnover
0.51 0.00 0.00 <0.01 0.00
Working Capital Turnover Ratio
1.76 0.00 0.00 <0.01 0.00
Cash Conversion Cycle
-546.99 0.00 0.00 9.39K 0.00
Days of Sales Outstanding
0.57 0.00 0.00 9.39K 0.00
Days of Inventory Outstanding
0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
547.57 0.00 0.00 0.00 0.00
Operating Cycle
0.57 0.00 0.00 9.39K 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
<0.01 -0.10 -0.12 -0.13 -0.09
Free Cash Flow Per Share
<0.01 -0.10 -0.12 -0.13 -0.09
CapEx Per Share
<0.01 0.00 0.00 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
1.00 1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
139.06K 0.00 0.00 -14.09K -5.14K
Capital Expenditure Coverage Ratio
139.06K 0.00 0.00 -14.09K -5.14K
Operating Cash Flow Coverage Ratio
2.42 -53.83 -41.38 -31.37 -8.69
Operating Cash Flow to Sales Ratio
0.03 0.00 0.00 -82.52 0.00
Free Cash Flow Yield
1.11%-1.18%-0.30%-0.16%-0.04%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
803.25 -80.06 -226.79 -631.99 -2.34K
Price-to-Sales (P/S) Ratio
2.40 0.00 0.00 52.16K 0.00
Price-to-Book (P/B) Ratio
180.03 70.92 220.31 241.63 428.20
Price-to-Free Cash Flow (P/FCF) Ratio
90.13 -84.49 -331.27 -632.06 -2.70K
Price-to-Operating Cash Flow Ratio
11.22K -84.49 -331.27 -632.10 -2.70K
Price-to-Earnings Growth (PEG) Ratio
35.75 1.94 -2.03 -20.54 124.98
Price-to-Fair Value
180.03 70.92 220.31 241.63 428.20
Enterprise Value Multiple
10.20 -71.67 -231.48 -659.09 -3.39K
Enterprise Value
20.73M 1.23B 4.84B 9.44B 15.29B
EV to EBITDA
10.20 -71.67 -231.48 -659.09 -3.39K
EV to Sales
1.32 0.00 0.00 52.04K 0.00
EV to Free Cash Flow
49.68 -83.65 -330.47 -630.55 -2.70K
EV to Operating Cash Flow
49.68 -83.65 -330.47 -630.59 -2.70K
Tangible Book Value Per Share
0.05 0.02 0.06 0.21 0.29
Shareholders’ Equity Per Share
0.11 0.12 0.18 0.35 0.55
Tax and Other Ratios
Effective Tax Rate
-0.04 <0.01 <0.01 <0.01 0.02
Revenue Per Share
0.07 0.00 0.00 <0.01 0.00
Net Income Per Share
0.02 -0.10 -0.17 -0.13 -0.10
Tax Burden
1.04 0.99 0.99 0.99 0.98
Interest Burden
4.08 0.88 1.00 1.00 1.15
Research & Development to Revenue
0.53 0.00 0.00 60.69 0.00
SG&A to Revenue
0.52 0.00 0.00 29.06 0.00
Stock-Based Compensation to Revenue
0.01 0.00 0.00 10.73 0.00
Income Quality
0.07 0.95 0.68 1.00 0.87
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis